Options on CPPI with guaranteed minimum equity exposure

Autor: Di Persio, L., Wallbaum, I. Oliva. K.

In the present paper we provide a two-step principal protection strategy obtained by combining a modification of the Constant Proportion Portfolio Insurance (CPPI) algorithm and a classical Option Based Portfolio Insurance (OBPI) mechanism. Such a no

Externí odkaz: http://arxiv.org/abs/1902.06505

Factors affecting the post-operative outcomes in patients aged over 80 following colorectal cancer surgery.

Autor: Yap R; Cabrini Monash University Department of Surgery, Cabrini Hospital, Malvern, VIC, 3144, Australia., Wilkins S; Cabrini Monash University Department of Surgery, Cabrini Hospital, Malvern, VIC, 3144, Australia. simonwilkins@cabrini.com.au.; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia. simonwilkins@cabrini.com.au., Asghari-Jafarabadi M; Cabrini Research, Cabrini Hospital, Malvern, VIC, 3144, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia., Oliva K; Cabrini Monash University Department of Surgery, Cabrini Hospital, Malvern, VIC, 3144, Australia., Wang WC; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.; Cabrini Research, Cabrini Hospital, Malvern, VIC, 3144, Australia., Centauri S; Cabrini Monash University Department of Surgery, Cabrini Hospital, Malvern, VIC, 3144, Australia., McMurrick PJ; Cabrini Monash University Department of Surgery, Cabrini Hospital, Malvern, VIC, 3144, Australia.

Publikováno v: International journal of colorectal disease [Int J Colorectal Dis] 2023 Jan 12; Vol. 38 (1), pp. 11. Date of Electronic Publication: 2023 Jan 12.

Impact of Anastomotic Leak on Long-term Oncological Outcomes After Restorative Surgery for Rectal Cancer: A Retrospective Cohort Study.

Autor: Engel RM; Department of Surgery, Cabrini Health, Cabrini Monash University, Malvern, Victoria, Australia.; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Stem Cells and Development Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Oliva K; Department of Surgery, Cabrini Health, Cabrini Monash University, Malvern, Victoria, Australia., Centauri S; Department of Surgery, Cabrini Health, Cabrini Monash University, Malvern, Victoria, Australia., Wang W; Cabrini Institute, Malvern, Victoria, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia., McMurrick PJ; Department of Surgery, Cabrini Health, Cabrini Monash University, Malvern, Victoria, Australia., Yap R; Department of Surgery, Cabrini Health, Cabrini Monash University, Malvern, Victoria, Australia.

Publikováno v: Diseases of the colon and rectum [Dis Colon Rectum] 2023 Jul 01; Vol. 66 (7), pp. 923-933. Date of Electronic Publication: 2022 Nov 23.

The effect of anti-spasmodic administration on the accuracy of magnetic resonance imaging staging of rectal cancer.

Autor: Taylor A; Departmentof Surgery, Cabrini Health, Cabrini Monash University, Melbourne, Victoria, Australia., Wilkins S; Departmentof Surgery, Cabrini Health, Cabrini Monash University, Melbourne, Victoria, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Gelber N; Department of Radiology, Cabrini Health, Melbourne, Victoria, Australia., Wang WC; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Cabrini Research, Cabrini Health, Melbourne, Victoria, Australia., Oliva K; Departmentof Surgery, Cabrini Health, Cabrini Monash University, Melbourne, Victoria, Australia., Yap R; Departmentof Surgery, Cabrini Health, Cabrini Monash University, Melbourne, Victoria, Australia., McMurrick P; Departmentof Surgery, Cabrini Health, Cabrini Monash University, Melbourne, Victoria, Australia., Ranchod P; Departmentof Surgery, Cabrini Health, Cabrini Monash University, Melbourne, Victoria, Australia.

Publikováno v: ANZ journal of surgery [ANZ J Surg] 2023 Jun; Vol. 93 (6), pp. 1613-1619. Date of Electronic Publication: 2023 Jan 04.

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy.

Autor: Gross EE; The University of Washington School of Medicine, Seattle, WA., Li M; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital Columbus, OH., Yin M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH., Orcutt D; The University of Washington School of Medicine, Seattle, WA., Hussey D; The University of Washington School of Medicine, Seattle, WA., Trott E; The University of Washington School of Medicine, Seattle, WA., Holt SK; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Dwyer ER; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Kramer J; The University of Washington School of Medicine, Seattle, WA., Oliva K; The University of Washington School of Medicine, Seattle, WA., Gore JL; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Schade GR; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Lin DW; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Tykodi SS; Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Hall ET; Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Thompson JA; Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Parikh A; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital Columbus, OH., Yang Y; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital Columbus, OH., Collier KA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH., Miah A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH., Mori-Vogt S; Department of Pharmacy, The Ohio State University James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH., Hinkley M; Department of Pharmacy, The Ohio State University James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH., Monk P; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital Columbus, OH., Folefac E; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH., Clinton SK; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH., Psutka SP; Department of Urology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: spsutka@uw.edu.

Publikováno v: Urologic oncology [Urol Oncol] 2023 Jan; Vol. 41 (1), pp. 51.e25-51.e31. Date of Electronic Publication: 2022 Oct 26.